Matthew R. Kwietniak - 25 Dec 2024 Form 4 Insider Report for Avid Bioservices, Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 Dec 2024, 19:30:48 UTC
Prior SEC filing
15 Oct 2024
Next SEC filing
07 Feb 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Stephen Hedberg, by Power of Attorney for Matthew R. Kwietniak

Key filing fact

Matthew R. Kwietniak filed Form 4 for Avid Bioservices, Inc. on 27 Dec 2024.

Key facts

  • This page summarizes Matthew R. Kwietniak's Form 4 filing for Avid Bioservices, Inc..
  • 14 reported transactions and 10 derivative rows are listed below.
  • Accepted by SEC: 27 Dec 2024, 19:30.

Change

  • Previous filing in this sequence was filed on 15 Oct 2024.
  • Current net transaction value: -$163,626.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDMO transaction

Common Stock, $0.001 par value

Options Exercise

Transaction value
Shares
+9,300
Change %
+37%
Price
Shares after
34,707
Date
25 Dec 2024
Ownership
Direct
Footnotes
F1, F2
CDMO transaction

Common Stock, $0.001 par value

Options Exercise

Transaction value
Shares
+29,479
Change %
+85%
Price
Shares after
64,186
Date
25 Dec 2024
Ownership
Direct
Footnotes
F1, F3
CDMO transaction

Common Stock, $0.001 par value

Sale

Transaction value
$39,410
Shares
-3,225
Change %
-5%
Price
$12.22
Shares after
60,961
Date
26 Dec 2024
Ownership
Direct
Footnotes
F4
CDMO transaction

Common Stock, $0.001 par value

Sale

Transaction value
$124,216
Shares
-10,165
Change %
-17%
Price
$12.22
Shares after
50,796
Date
26 Dec 2024
Ownership
Direct
Footnotes
F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CDMO transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
$0
Shares
-1,005
Change %
-1.3%
Price
$0.000000
Shares after
74,107
Date
25 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,005
Exercise price
Footnotes
F2, F6
CDMO transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
$0
Shares
-1,893
Change %
-2.6%
Price
$0.000000
Shares after
72,214
Date
25 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,893
Exercise price
Footnotes
F2, F7
CDMO transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
$0
Shares
-1,908
Change %
-2.6%
Price
$0.000000
Shares after
70,306
Date
25 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,908
Exercise price
Footnotes
F2, F8
CDMO transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
$0
Shares
-4,494
Change %
-6.4%
Price
$0.000000
Shares after
65,812
Date
25 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,494
Exercise price
Footnotes
F2, F9
CDMO transaction Derivative

Performance Stock Units (FY 2023 Grant)

Disposed to Issuer

Transaction value
$0
Shares
-6,725
Change %
-4.9%
Price
$0.000000
Shares after
130,568
Date
25 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,725
Exercise price
Footnotes
F3, F10, F11
CDMO transaction Derivative

Performance Stock Units (FY 2023 Grant)

Disposed to Issuer

Transaction value
$0
Shares
-6,725
Change %
-5.2%
Price
$0.000000
Shares after
123,843
Date
25 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,725
Exercise price
Footnotes
F3, F10, F12
CDMO transaction Derivative

Performance Stock Units (FY 2024 Grant)

Disposed to Issuer

Transaction value
$0
Shares
-6,782
Change %
-5.5%
Price
$0.000000
Shares after
117,061
Date
25 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,782
Exercise price
Footnotes
F3, F10, F11
CDMO transaction Derivative

Performance Stock Units (FY 2024 Grant)

Disposed to Issuer

Transaction value
$0
Shares
-6,782
Change %
-5.8%
Price
$0.000000
Shares after
110,279
Date
25 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,782
Exercise price
Footnotes
F3, F10, F12
CDMO transaction Derivative

Performance Stock Units (FY 2025 Grant)

Disposed to Issuer

Transaction value
$0
Shares
-15,972
Change %
-14%
Price
$0.000000
Shares after
94,307
Date
25 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,972
Exercise price
Footnotes
F3, F10, F11
CDMO transaction Derivative

Performance Stock Units (FY 2025 Grant)

Disposed to Issuer

Transaction value
$0
Shares
-15,972
Change %
-17%
Price
$0.000000
Shares after
78,335
Date
25 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,972
Exercise price
Footnotes
F3, F10, F12
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 12 footnotes

Footnote F1

In connection with the anticipated transactions contemplated by the Agreement and Plan of Merger (the "Merger Agreement") whereby the Issuer will be acquired by funds managed by affiliates of GHO Capital Partners LLP and Ampersand Capital Partners, the Board of Directors of the Issuer accelerated the payment of certain equity awards in connection with certain actions to mitigate adverse tax consequences of Section 280G and Section 4999 of the Internal Revenue Code of 1986 (as amended) that could arise in connection with the anticipated transactions under the Merger Agreement. The accelerated settlement of equity awards reported in this Form 4 was contingent upon the reporting person's agreement to repay accelerated compensation amounts under certain conditions.

Footnote F2

Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.

Footnote F3

Each performance stock unit ("PSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.

Footnote F4

Represents the shares sold by the reporting person pursuant to a contractual election to satisfy tax withholding obligations in connection with the vesting of the RSUs described in footnotes 6 through 9. This sale does not represent a discretionary trade by the reporting person.

Footnote F5

Represents the shares sold by the reporting person pursuant to a contractual election to satisfy tax withholding obligations in connection with the vesting of the PSUs described in footnotes 10 and 11. This sale does not represent a discretionary trade by the reporting person.

Footnote F6

Represents RSUs granted to the reporting person on October 11, 2021 that are scheduled to vest over a four (4) year period. 25% vested on the first anniversary of the date of grant, and the remaining balance were scheduled to vest in twelve (12) equal quarterly installments beginning January 11, 2023, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.

Footnote F7

Represents RSUs granted to the reporting person on July 9, 2022 that were scheduled to vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2022, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.

Footnote F8

Represents RSUs granted to the reporting person on July 9, 2023 that were scheduled to vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2023, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.

Footnote F9

Represents RSUs granted to the reporting person on July 9, 2024 that were scheduled to vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2024, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.

Footnote F10

The PSUs granted to the reporting person were subject to the Issuer achieving certain fiscal year financial milestones over three (3) consecutive fiscal year performance periods (i.e., May 1 to April 30) commencing with the fiscal year in which the PSU was initially granted (each fiscal year a "Performance Period"). Subject to the Issuer attaining the applicable fiscal year milestones, 1/3rd of the PSUs were scheduled to vest on the last day of each fiscal year during the Performance Period, subject to the reporting person's continuous service to the Issuer on such vesting dates. The number of PSUs initially reported by the reporting person was based on a maximum 200% achievement of each milestone during each Performance Period (the "Maximum Performance Target"). If a milestone was achieved at a rate below the Maximum Performance Target, or was not achieved, the corresponding portion of the PSUs that did not vest would be forfeited.

Footnote F11

Vested PSUs settled into shares of the Issuer's Common Stock on December 25, 2024.

Footnote F12

Represents the forfeiture of unearned PSUs for the Performance Period ending April 30, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .